• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白启动子多态性对钙结石形成风险的影响。

The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.

机构信息

Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Clin Chim Acta. 2010 May 2;411(9-10):739-43. doi: 10.1016/j.cca.2010.02.007. Epub 2010 Feb 6.

DOI:10.1016/j.cca.2010.02.007
PMID:20144595
Abstract

BACKGROUND

Osteopontin (OPN) is an important modulator of urolithiasis formation. Three functional polymorphisms (-66T/G, -156delG/G, and -443T/G) on the promoter region of the OPN gene have been found to affect the gene expression and transcriptional activity. This study investigated the association of those three functional polymorphisms with the risk of calcium urolithiasis.

METHODS

A total of 249 cases diagnosed with calcium urolithiasis and 247 age- and sex-matched healthy controls were recruited from Kaohsiung Medical University Hospital between June, 2003 and February, 2007. All subjects completed a detailed questionnaire survey, and provided blood and urine samples for biochemical evaluations. Three single nucleotide polymorphisms were determined by using TaqMan 5' allelic discrimination assay.

RESULTS

In-156delG/G polymorphism, subjects who carried delG allele had a significantly higher risk of developing calcium urolithiasis than those with G allele (odds ratio=1.39; 95% confidence interval=1.02-1.90; P=0.037). In stone cases, subjects with delG/G and delG/delG genotypes also had significantly higher urinary ratio of calcium to OPN than those with G/G genotype (11.8+/-15.9 vs 7.08+/-5.26, P=0.021).

CONCLUSIONS

The -156 delG/G polymorphism of OPN gene could serve as a candidate genetic marker used to evaluate the risk of calcium urolithiasis.

摘要

背景

骨桥蛋白(OPN)是尿石形成的重要调节剂。在 OPN 基因启动子区域发现了三个功能多态性(-66T/G、-156delG/G 和-443T/G),它们影响基因表达和转录活性。本研究调查了这三个功能多态性与钙结石形成风险的关系。

方法

2003 年 6 月至 2007 年 2 月,高雄医学大学附属医院共招募了 249 例钙结石患者和 247 例年龄和性别匹配的健康对照者。所有受试者均完成了详细的问卷调查,并提供了血液和尿液样本进行生化评估。采用 TaqMan 5'等位基因鉴别分析测定三个单核苷酸多态性。

结果

在-156delG/G 多态性中,携带 delG 等位基因的受试者发生钙结石的风险明显高于携带 G 等位基因的受试者(比值比=1.39;95%置信区间=1.02-1.90;P=0.037)。在结石病例中,delG/G 和 delG/delG 基因型的受试者尿液钙与 OPN 的比值也明显高于 G/G 基因型的受试者(11.8+/-15.9 比 7.08+/-5.26,P=0.021)。

结论

OPN 基因的-156delG/G 多态性可作为评估钙结石形成风险的候选遗传标志物。

相似文献

1
The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis.骨桥蛋白启动子多态性对钙结石形成风险的影响。
Clin Chim Acta. 2010 May 2;411(9-10):739-43. doi: 10.1016/j.cca.2010.02.007. Epub 2010 Feb 6.
2
Association of vitamin D receptor (Fok-I) polymorphism with the clinical presentation of calcium urolithiasis.维生素D受体(Fok-I)基因多态性与钙性尿路结石临床表现的相关性
BJU Int. 2007 Jun;99(6):1534-8. doi: 10.1111/j.1464-410X.2007.06792.x. Epub 2007 Apr 5.
3
Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.骨桥蛋白启动子多态性与尿石症风险:一项候选基因关联及荟萃分析研究
BMC Med Genet. 2020 Aug 25;21(1):172. doi: 10.1186/s12881-020-01101-2.
4
The impact of cigarette smoking, alcohol drinking and betel quid chewing on the risk of calcium urolithiasis.吸烟、饮酒和嚼槟榔对钙结石形成风险的影响。
Ann Epidemiol. 2009 Aug;19(8):539-45. doi: 10.1016/j.annepidem.2009.02.006. Epub 2009 Apr 17.
5
Heterozygote AG variant of -596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL).白细胞介素-6(IL-6)基因-596 A/G多态性的杂合子AG变异是皮肤T细胞淋巴瘤(CTCL)的一个标志物。
Clin Immunol. 2004 Dec;113(3):256-60. doi: 10.1016/j.clim.2004.08.010.
6
The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease.年龄对KLOTHO基因多态性与冠状动脉疾病关联的差异影响。
Metabolism. 2006 Oct;55(10):1344-51. doi: 10.1016/j.metabol.2006.05.020.
7
OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis.OPN 基因多态性(Ala250)和血清 OPN 水平降低与尿石症有关。
Ren Fail. 2013 Jul;35(6):825-9. doi: 10.3109/0886022X.2013.794431. Epub 2013 May 21.
8
Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis.血浆骨桥蛋白水平升高与银屑病的发生相关,并且是银屑病患者心血管疾病的不良危险因素。
J Am Acad Dermatol. 2009 Feb;60(2):225-30. doi: 10.1016/j.jaad.2008.09.046. Epub 2008 Nov 25.
9
SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.骨桥蛋白基因启动子区域的单核苷酸多态性作为预测慢性丙型肝炎患者基于干扰素治疗疗效的标志物。
J Gastroenterol. 2005 Apr;40(4):381-8. doi: 10.1007/s00535-005-1558-3.
10
The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.功能性-443T/C骨桥蛋白启动子多态性通过c-Myb转录因子的结合影响黑色素瘤细胞中骨桥蛋白基因的表达。
Mol Carcinog. 2009 Jan;48(1):14-23. doi: 10.1002/mc.20452.

引用本文的文献

1
SPP1 is a plasma biomarker associated with the dia gnosis and prediction of prognosis in sepsis.SPP1 是一种与脓毒症诊断和预后预测相关的血浆生物标志物。
Sci Rep. 2024 Nov 8;14(1):27205. doi: 10.1038/s41598-024-78420-4.
2
Current Status of Protein Biomarkers in Urolithiasis-A Review of the Recent Literature.尿路结石中蛋白质生物标志物的现状——近期文献综述
J Clin Med. 2023 Nov 16;12(22):7135. doi: 10.3390/jcm12227135.
3
Osteopontin phosphopeptide mitigates calcium oxalate stone formation in a Drosophila melanogaster model.骨桥蛋白磷酸肽可减轻果蝇模型中草酸钙结石的形成。
Urolithiasis. 2022 Dec 22;51(1):19. doi: 10.1007/s00240-022-01395-2.
4
Genetic Polymorphisms and Kidney Stones Around the Globe: A Systematic Review and Meta-Analysis.全球范围内的基因多态性与肾结石:一项系统评价和荟萃分析
Front Genet. 2022 Jun 30;13:913908. doi: 10.3389/fgene.2022.913908. eCollection 2022.
5
Genetic Polymorphisms of MnSOD Modify the Impacts of Environmental Melamine on Oxidative Stress and Early Kidney Injury in Calcium Urolithiasis Patients.锰超氧化物歧化酶的基因多态性改变环境中三聚氰胺对含钙尿路结石患者氧化应激和早期肾损伤的影响。
Antioxidants (Basel). 2022 Jan 13;11(1):152. doi: 10.3390/antiox11010152.
6
Association between intelectin-1 variation and human kidney stone disease in northeastern Thai population.泰国东北部人群中内凝集素-1 变异与人类肾结石病的关联。
Urolithiasis. 2021 Dec;49(6):521-532. doi: 10.1007/s00240-021-01267-1. Epub 2021 May 26.
7
Osteopontin promoter polymorphisms and risk of urolithiasis: a candidate gene association and meta-analysis study.骨桥蛋白启动子多态性与尿石症风险:一项候选基因关联及荟萃分析研究
BMC Med Genet. 2020 Aug 25;21(1):172. doi: 10.1186/s12881-020-01101-2.
8
A novel loss-of-function mutation of PBK associated with human kidney stone disease.一种与人类肾结石疾病相关的新型 PBK 功能丧失突变。
Sci Rep. 2020 Jun 24;10(1):10282. doi: 10.1038/s41598-020-66936-4.
9
Genetics of kidney stone disease.肾结石病的遗传学。
Nat Rev Urol. 2020 Jul;17(7):407-421. doi: 10.1038/s41585-020-0332-x. Epub 2020 Jun 12.
10
The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.骨桥蛋白糖基化对尿石形成的影响。
Int J Mol Sci. 2019 Dec 21;21(1):93. doi: 10.3390/ijms21010093.